Retraction: Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine (PLoS ONE (2013) 8:8 (E74022) DOI: 10.1371/journal.pone.0074022);Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kim, Shin Hee ^a   Wanasen, Nanchaya ^a   Paldurai, Anandan ^a   Xiao, Sa ^a   Collins, Peter L ^b   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

F PROTEIN; HN PROTEIN; NEWCASTLE DISEASE VACCINE; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; DEATH; DRUG EFFICACY; EMBRYO; F GENE; GENOTYPE; HN GENE; HUMAN; HUMAN CELL; INFECTION PREVENTION; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; OPEN READING FRAME; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE;

GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

ANIMALS; CELL LINE, TUMOR; CHICK EMBRYO; CHICKENS; HUMANS; IMMUNIZATION; MUTATION; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; VIRAL FUSION PROTEINS; VIRAL VACCINES;

EID: 84883391227     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0244074     Document Type: Erratum

References (36)

1. Alexander DJ, (1989) Newcastle disease, In: Purchase HG, Arp LH, Domermuth CH, Pearson JE, eds. A laboratory manual for the isolation and identification of avian pathogens, 3rd ed. The American Association of Avian Pathologists, Kendall/Hunt Publishing Company. pp. pp. 114-120.
2. Lamb R, Parks G, (2007) Paramyxoviridae: the viruses and their replication, In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, eds. Philadelphia: Lippincott Williams & Wilkins. pp. pp. 1449-1496.
3. Lamb RA, Paterson RG, Jardetzky TS, (2006) Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 344: 30-37. doi:10.1016/j.virol.2005.09.007. PubMed: 16364733.
4. Deng RZ, Wang A, Mirza M, Iorio RM, (1995) Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 209: 457-469. doi:10.1006/viro.1995.1278. PubMed: 7778280.
5. Melanson VR, Iorio RM, (2004) Amino acid substitutions in the F-specific domain in the stalk of the Newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J Virol 78: 13053-13061. doi:10.1128/JVI.78.23.13053-13061.2004. PubMed: 15542657.
6. Pedersen JC, Senne DA, Woolcock PR, Kinde H, King DJ, et al. (2004) Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North America. J Clin Microbiol 42: 2329-2334. doi:10.1128/JCM.42.5.2329-2334.2004. PubMed: 15131226.
7. Samal SK, (2011) Newcastle disease and related avian paramyxoviruses, In: Samal SK, eds. The biology of paramyxoviruses. Caister Academic Press. pp. pp. 69-114.
8. Miller PJ, Decanini EL, Afonso CL, (2010) Newcastle disease: evolution of genotypes and the related diagnostic challenges. Infect Genet Evol 10: 26-35. doi:10.1016/j.meegid.2009.09.012. PubMed: 19800028.
9. Kim SH, Nayak S, Paldurai A, Nayak B, Samuel A, et al. (2012) Complete genome sequence of a novel Newcastle disease virus strain isolated from a chicken in West Africa. J Virol 86: 11394-11395. doi:10.1128/JVI.01922-12. PubMed: 22997417.
10. Diel DG, da Silva LHA, Liu H, Wang Z, Miller PJ, et al. (2012) Genetic diversity of avian paramyxovirus type 1: Proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect Genet Evol 12: 1770-1779. doi:10.1016/j.meegid.2012.07.012. PubMed: 22892200.
11. Aldous EW, Fuller CM, Mynn JK, Alexander DJ, (2004) A molecular epidemiological investigation of isolates of the variant avian paramyxovirus type 1 virus (PPMV-1) responsible for the 1978 to present panzootic in pigeons. Avian Pathol 33: 258-269. doi:10.1080/0307945042000195768. PubMed: 15276997.
12. Cattoli G, et al. (2010) Emergence of a new genetic lineage of Newcastle disease virus in West and Cwntral Africa-implications for diagnosis and control. Vet Micobiol 142: 168-176.
13. Khan ST, Rehmani, Rue C, Miller P, Afonso CL, (2010) Phylogenetic and pathological characterization of Newcastle disease virus isolates from Pakistan. J Clin Microbiol 48: 1892-1894. doi:10.1128/JCM.00148-10. PubMed: 20237105.
14. Liu XF, Wan HQ, Ni XX, Wu YT, Liu WB, (2003) Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985-2001. Arch Virol 148: 1387-1403. PubMed: 12827467.
15. Miller PJ, King DJ, Afonso CL, Suarez DL, (2007) Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25: 7238-7246. doi:10.1016/j.vaccine.2007.07.017. PubMed: 17719150.
16. Miller PJ, Estevez C, Yu Q, Suarez DL, King DK, (2009) Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian Dis 53: 39-49. doi:10.1637/8407-071208-Reg.1. PubMed: 19432002.
17. Xiao S, Nayak B, Samuel A, Paldurai A, Kanabagattebasavarajappa M, et al. (2012) Generation by reverse genetics of an effective, stable, live-attenuated Newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain. PLOS ONE 7: e52751.
18. Xiao S, Paldurai A, Nayak B, Samuel A, Bharoto EE, et al. (2012) Complete genome sequences of Newcastle disease virus strains circulating in chicken populations of Indonesia. J Virol 86: 5969-5970. doi:10.1128/JVI.00546-12. PubMed: 22532534.
19. Huang Z, Krishnamurthy S, Panda A, Samal SK, (2001) High-level expression of a foreign gene from the 3́ proximal first locus of a recombinant Newcastle disease virus. J Gen Virol 82: 1729-1736. PubMed: 11413385.
20. Krishnamurthy S, Huang Z, Samal SK, (2000) Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278: 168-182. doi:10.1006/viro.2000.0618. PubMed: 11112492.
21. Samal S, Kumar S, Khattar SK, Samal SK, (2011) A single amino acid change Q114R in cleavage site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogennicity. J Gen Virol 92: 2333-2338. doi:10.1099/vir.0.033399-0. PubMed: 21677091.
22. Kim SH, Xiao S, Shive H, Collins PL, Samal SK, (2012) Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1-9 in chickens and ducks. PLOS ONE 7: e34927. doi:10.1371/journal.pone.0034927. PubMed: 22558104.
23. Reed LJ, Muench HA, (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.
24. Kim SH, Subbiah M, Samuel AS, Collins PL, Samal SK, (2011) Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses. J Virol 85: 8582-8596. doi:10.1128/JVI.00652-11. PubMed: 21680512.
25. Peter HD, Robinson WS, (1965) Isolation of the Newcastle disease virus. Proc Natl Acad Sci U S A 54: 794-800. doi:10.1073/pnas.54.3.794. PubMed: 5217460.
26. Cho SH, Kwon HJ, Kim TE, Kim JH, Yoo HS, et al. (2008) Characterization of a recombinant Newcastle disease vaccine strain. Clin Vaccine Immunol 15: 1572-1579. doi:10.1128/CVI.00156-08. PubMed: 18768673.
27. Perozo F, Marcano R, Afonso CL, (2012) Biological and Phylogenetic Characterization of a Genotype VII Newcastle Disease Virus from Venezuela: Efficacy of Field Vaccination. J Clin Microbiol 50: 1204-1208. doi:10.1128/JCM.06506-11. PubMed: 22238433.
28. Hu S, Ma H, Wu Y, Liu W, Wang X, et al. (2009) vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 27: 904-910. doi:10.1016/j.vaccine.2008.11.091. PubMed: 19095026.
29. Boursnell ME, et al. (1990) A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 78: 297-300. PubMed: 2167557.
30. Cosset FL, et al. (1991) Newcastle disease virus (NDV) vaccine based on immunization with avian cells expressing the NDV hemagglutinin-neuraminidase glycoprotein. Virology 185: 862-866. doi:10.1016/0042-6822(91)90560-X. PubMed: 1660204.
31. Karaca K, et al. (1998) Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 16: 1496-1503. doi:10.1016/S0264-410X(97)00295-8. PubMed: 9711795.
32. Qin ZM, Tan LT, Xu HY, Ma BC, Wang YL, et al. (2008) Pathotypical characterization and molecular epidemiology of Newcastle disease virus isolates from different hosts in China from 1996 to 2005 J. Clin Microbiol 46: 601-611. doi:10.1128/JCM.01356-07.
33. Jeon WJ, Lee EK, Lee YJ, Jeong OM, Kim YJ, et al. (2008) Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain. J Vet Sci 9: 295-300. doi:10.4142/jvs.2008.9.3.295. PubMed: 18716450.
34. Liu XF, Wan HQ, Ni XX, Wu YT, Liu WB, (2003) Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985-2001. Arch Virol 148: 1387-1403. PubMed: 12827467.
35. Dortmans JC, Peeters BP, Koch G, (2012) Newcastle disease virus outbreaks: vaccine mismatch or inadequate application? Vet Microbiol 160: 17-22. doi:10.1016/j.vetmic.2012.05.003. PubMed: 22655976.
36. Moss B, Elroy-Stein O, Mizukami T, Alexander WA, Fuerst TR, (1990) Product review. New mammalian expression vectors. Nature 348: 91-92. doi:10.1038/348091a0. PubMed: 2234068.